{"id":"https://openalex.org/W4393071817","doi":"https://doi.org/10.1158/1538-7445.am2024-2913","title":"Abstract 2913: Co-expression of extracellular matrix enzymes heparanase or PH-20 augments the anti-tumor efficacy of folate receptor 1-targeting CAR T cells in an ovarian cancer model","display_name":"Abstract 2913: Co-expression of extracellular matrix enzymes heparanase or PH-20 augments the anti-tumor efficacy of folate receptor 1-targeting CAR T cells in an ovarian cancer model","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393071817","doi":"https://doi.org/10.1158/1538-7445.am2024-2913"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-2913","doi":"https://doi.org/10.1158/1538-7445.am2024-2913","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-2913","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054693070","display_name":"Brittany L. Steimle","orcid":"https://orcid.org/0000-0003-3638-8767","observed_orcids":["https://orcid.org/0000-0003-3638-8767"]},"institutions":[{"id":"https://openalex.org/I4210126252","display_name":"Lentigen Technology (United States)","ror":"https://ror.org/0333j1f77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brittany L. Steimle","raw_affiliation_strings":["1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD","institution_ids":["https://openalex.org/I4210126252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064571896","display_name":"Peirong Hu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126252","display_name":"Lentigen Technology (United States)","ror":"https://ror.org/0333j1f77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peirong Hu","raw_affiliation_strings":["1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD","institution_ids":["https://openalex.org/I4210126252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101393583","display_name":"Ngoc Tran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126252","display_name":"Lentigen Technology (United States)","ror":"https://ror.org/0333j1f77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ngoc Tran","raw_affiliation_strings":["1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD","institution_ids":["https://openalex.org/I4210126252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035058458","display_name":"Jia\u2010Jye Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126252","display_name":"Lentigen Technology (United States)","ror":"https://ror.org/0333j1f77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jia-Jye Lee","raw_affiliation_strings":["1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD","institution_ids":["https://openalex.org/I4210126252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049641792","display_name":"Kathleen Baysac","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126252","display_name":"Lentigen Technology (United States)","ror":"https://ror.org/0333j1f77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen Baysac","raw_affiliation_strings":["1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD","institution_ids":["https://openalex.org/I4210126252"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kun Luo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126252","display_name":"Lentigen Technology (United States)","ror":"https://ror.org/0333j1f77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kun Luo","raw_affiliation_strings":["1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD","institution_ids":["https://openalex.org/I4210126252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100407929","display_name":"Xu Wang","orcid":"https://orcid.org/0000-0003-1094-1843","observed_orcids":["https://orcid.org/0000-0003-1094-1843"]},"institutions":[{"id":"https://openalex.org/I4210126252","display_name":"Lentigen Technology (United States)","ror":"https://ror.org/0333j1f77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xu Wang","raw_affiliation_strings":["1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD","institution_ids":["https://openalex.org/I4210126252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109074060","display_name":"Genqing Liang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126252","display_name":"Lentigen Technology (United States)","ror":"https://ror.org/0333j1f77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Genqing Liang","raw_affiliation_strings":["1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD","institution_ids":["https://openalex.org/I4210126252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040299976","display_name":"Saule T. Nurmukhambetova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126252","display_name":"Lentigen Technology (United States)","ror":"https://ror.org/0333j1f77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saule Nurmukhambetova","raw_affiliation_strings":["1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD","institution_ids":["https://openalex.org/I4210126252"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Tri Tran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126252","display_name":"Lentigen Technology (United States)","ror":"https://ror.org/0333j1f77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tri Tran","raw_affiliation_strings":["1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD","institution_ids":["https://openalex.org/I4210126252"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071766732","display_name":"Pradyot Dash","orcid":"https://orcid.org/0000-0001-5467-0657","observed_orcids":["https://orcid.org/0000-0001-5467-0657"]},"institutions":[{"id":"https://openalex.org/I4210126252","display_name":"Lentigen Technology (United States)","ror":"https://ror.org/0333j1f77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pradyot Dash","raw_affiliation_strings":["1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD","institution_ids":["https://openalex.org/I4210126252"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085201883","display_name":"Dina Schneider","orcid":"https://orcid.org/0000-0001-7130-7374","observed_orcids":["https://orcid.org/0000-0001-7130-7374"]},"institutions":[{"id":"https://openalex.org/I4210126252","display_name":"Lentigen Technology (United States)","ror":"https://ror.org/0333j1f77","country_code":"US","type":"company","lineage":["https://openalex.org/I4210126252"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dina Schneider","raw_affiliation_strings":["1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Lentigen Technology Inc., a Miltenyi Biotec Company, Gaithersburg, MD","institution_ids":["https://openalex.org/I4210126252"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210126252"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"2913","last_page":"2913"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Bacterial Cancer Therapy","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.6589999794960022},{"id":"https://openalex.org/keywords/folate-receptor-1","display_name":"folate receptor 1","score":0.8980000019073486},{"id":"https://openalex.org/keywords/heparanase","display_name":"heparanase","score":0.9369999766349792},{"id":"https://openalex.org/keywords/ph-20","display_name":"PH-20","score":0.9800000190734863},{"id":"https://openalex.org/keywords/extracellular-matrix-remodeling","display_name":"extracellular matrix remodeling","score":0.7879999876022339},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7099999785423279},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.6510000228881836},{"id":"https://openalex.org/keywords/perlecan","display_name":"perlecan","score":0.6740000247955322},{"id":"https://openalex.org/keywords/hyaluronic-acid","display_name":"hyaluronic acid","score":0.9539999961853027},{"id":"https://openalex.org/keywords/glypican-3","display_name":"glypican-3","score":0.9390000104904175},{"id":"https://openalex.org/keywords/syndecan-1","display_name":"syndecan-1","score":0.7400000095367432},{"id":"https://openalex.org/keywords/cytokine-production","display_name":"cytokine production","score":0.453000009059906}],"concepts":[{"id":"https://openalex.org/C2777478136","wikidata":"https://www.wikidata.org/wiki/Q909646","display_name":"Heparanase","level":4,"score":0.8708508014678955},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6742256283760071},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5452142953872681},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5223209261894226},{"id":"https://openalex.org/C189165786","wikidata":"https://www.wikidata.org/wiki/Q193825","display_name":"Extracellular matrix","level":2,"score":0.5122677683830261},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.49546921253204346},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4354996383190155},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3627665936946869},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2698628902435303},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.225000262260437},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.1331782341003418},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1298312544822693}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-2913","doi":"https://doi.org/10.1158/1538-7445.am2024-2913","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-2913","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7164373311","https://openalex.org/W2347181373","https://openalex.org/W2067319054","https://openalex.org/W4409909607","https://openalex.org/W4390822207","https://openalex.org/W4362540773","https://openalex.org/W7163919074","https://openalex.org/W7131819161","https://openalex.org/W4283376329","https://openalex.org/W1996860254"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"The":[2,360],"tumor":[3,44,141,256,294,309,357,386],"extracellular":[4,437],"matrix":[5,438],"(ECM)":[6],"is":[7],"a":[8,32,55,70,82,168],"physical":[9,43],"barrier":[10,46],"which":[11],"obstructs":[12],"trafficking":[13],"of":[14,51,103,236,352,373,436,447,462],"CAR":[15,33,53,92,109,238,243,277,283,315,320,451],"T":[16,93,101,192,231,284,298,321,452],"cells":[17,94,102,232,257,285,299,453],"to":[18,275,293,313,348],"tumors.":[19,343,407],"We":[20],"hypothesize":[21],"that":[22,336],"co-expressing":[23,304],"ECM":[24,61,143,160,240,245,261,302,353,365,396],"remodeling/degrading":[25],"enzymes":[26,366,439],"heparanase":[27,440],"(HPSE)":[28],"or":[29,88,265,296,306,368,441],"PH-20":[30,90,118,157,217,266,307,369,442],"with":[31,69,139,258,263,329,364,405],"directed":[34],"against":[35],"folate":[36,448],"receptor":[37,449],"1":[38,473],"(FolR1)":[39],"will":[40],"overcome":[41],"the":[42,350,356,444,463],"microenvironment":[45],"and":[47,73,77,85,99,117,124,130,148,156,182,207,216,239,244,253,289,384],"improve":[48,400],"anti-tumor":[49,445],"efficacy":[50,162,446],"anti-FolR1":[52,67,276,282,314,330,337,361],"in":[54,135,165,176,202,223,326,355,382,388,393,403,454],"human":[56,224],"ovarian":[57,172,203,225,390,406,456],"cancer":[58,173,204,391,457],"model.":[59],"Methods:":[60],"CARs":[62,246,262,303,331,338,354,362,397],"were":[63,95,120,133,152,186,219],"constructed":[64],"by":[65,81,106,113,210,221],"combining":[66],"ScFv":[68],"CD8":[71],"hinge":[72],"transmembrane":[74],"domain,":[75],"4-1BB,":[76],"CD3\u03b6":[78],"endodomains,":[79],"followed":[80],"P2A":[83],"element":[84],"full-length":[86],"HPSE":[87,116,155,211,264,305,367],"GPI-anchored":[89],"sequence.":[91],"prepared":[96],"from":[97],"CD4+":[98],"CD8+":[100],"healthy":[104],"donors":[105],"lentiviral":[107],"transduction.":[108],"expression":[110,119,199,235],"was":[111,163,200],"evaluated":[112,164],"flow":[114],"cytometry;":[115],"measured":[121],"via":[122],"ELISA":[123],"Western":[125],"blotting,":[126],"respectively.":[127,159],"CAR-mediated":[128],"killing":[129],"cytokine":[131],"release":[132],"observed":[134],"overnight":[136],"co-culture":[137],"assays":[138],"FolR1-expressing":[140,169,374],"cells.":[142],"CARs\u2019":[144,161],"migration":[145,269],"through":[146,270,379],"CultrexTM":[147],"sodium":[149],"hyaluronate":[150],"matrices":[151,272,381],"assessed":[153],"for":[154,194,466],"function,":[158],"vivo":[166],"using":[167],"subcutaneous":[170],"OV90":[171,184,287,342],"xenograft":[174],"model":[175,392,458],"NOD":[177],"SCID":[178],"Gamma":[179],"(NSG)":[180],"mice,":[181],"representative":[183],"tumors":[185,288],"harvested":[187],"at":[188],"day":[189],"7":[190],"post-CAR":[191],"treatment":[193],"immunohistochemical":[195],"staining.":[196],"Results:":[197],"FolR1":[198,237],"confirmed":[201],"cell":[205,322,375],"lines":[206],"substrates":[208],"targeted":[209],"(perlecan,":[212],"glypican":[213],"3,":[214],"CD138)":[215],"(hyaluronan)":[218],"detected":[220],"immunofluorescence":[222],"tumors\u2019":[226],"sections.":[227],"Lentiviral":[228],"transduced":[229],"primary":[230],"yielded":[233],"robust":[234],"enzymes.":[241],"Anti-FolR1":[242],"secreted":[247],"pro-inflammatory":[248],"cytokines":[249],"IL-2,":[250],"TNF\u03b1,":[251],"IFN\u01b3":[252],"lysed":[254],"OVCAR3":[255],"similar":[259],"efficacy.":[260],"exhibited":[267],"enhanced":[268],"ECM-rich":[271,380],"as":[273,311],"compared":[274,292,312],"alone.":[278,316],"In":[279],"vivo,":[280],"all":[281],"rejected":[286],"extended":[290],"survival":[291],"alone":[295],"untransduced":[297],"(UTD).":[300],"However,":[301],"accelerated":[308,385],"regression":[310,387],"Tumor":[317],"histology":[318],"revealed":[319],"infiltration":[323],"(CD3+,":[324],"CD8+)":[325],"mice":[327],"treated":[328],"but":[332],"not":[333],"UTD,":[334],"indicating":[335],"can":[339],"effectively":[340],"infiltrate":[341],"Imaging":[344],"studies":[345],"are":[346],"underway":[347],"evaluate":[349],"function":[351],"microenvironment.":[358],"Conclusions:":[359],"boosted":[363],"demonstrated":[370],"specific":[371],"lysis":[372],"lines,":[376],"improved":[377],"penetration":[378],"vitro,":[383],"an":[389,455],"vivo.":[394],"Therefore,":[395],"may":[398],"help":[399],"clinical":[401],"outcomes":[402],"patients":[404],"Citation":[408],"Format:":[409],"Brittany":[410],"L.":[411],"Steimle,":[412],"Peirong":[413],"Hu,":[414],"Ngoc":[415],"Tran,":[416,430],"Jia-Jye":[417],"Lee,":[418],"Kathleen":[419],"Baysac,":[420],"Kun":[421],"Luo,":[422],"Xu":[423],"Wang,":[424],"Genqing":[425],"Liang,":[426],"Saule":[427],"Nurmukhambetova,":[428],"Tri":[429],"Pradyot":[431],"Dash,":[432],"Dina":[433],"Schneider.":[434],"Co-expression":[435],"augments":[443],"1-targeting":[450],"[abstract].":[459],"In:":[460],"Proceedings":[461],"American":[464],"Association":[465],"Cancer":[467,485],"Research":[468],"Annual":[469],"Meeting":[470],"2024;":[471],"Part":[472],"(Regular":[474],"Abstracts);":[475],"2024":[476],"Apr":[477],"5-10;":[478],"San":[479],"Diego,":[480],"CA.":[481],"Philadelphia":[482],"(PA):":[483],"AACR;":[484],"Res":[486],"2024;84(6_Suppl):Abstract":[487],"nr":[488],"2913.":[489]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-03-23T00:00:00"}